Skip to main content

Blog

PPMD Honored with RAPS 2026 Patient-Centered Health Award

...

FDA Accepts Dyne Therapeutics’ Biologics License Application for Z-Rostudirsen

...

Highlights from PPMD’s 2026 Annual Conference

...

Preparing for the Deramiocel FDA Advisory Committee Meeting: How to Submit Written Testimony

...

FDA Accepts sNDAs to Review Traditional Approval for AMONDYS 45 and VYONDYS 53

...

Catching Up on PPMD’s 2026 Annual Conference: Part II

...

Catching up on What’s Happening at PPMD’S 2026 Annual Conference

...

Solid Biosciences Shares Updates on SGT-003

...

Capricor Therapeutics Shares Positive Five-Year HOPE-2 OLE Data for Deramiocel in Duchenne

...

FDA Announces Advisory Committee Meeting to Review Capricor Therapeutics’ Biologics License Application for Deramiocel

...